DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness

Journal of Gastroenterology

Volumn 46, Issue 2, 2011, Pages 153-163

  Toiyama, Yuji ^a   Inoue, Yasuhiro ^a   Yasuda, Hiromi ^a   Saigusa, Susumu ^a   Yokoe, Takeshi ^a   Okugawa, Yoshinaga ^a   Tanaka, Koji ^a   Miki, Chikao ^a   Kusunoki, Masato ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Cancer invasion; Carcinogenesis; Colorectal cancer; DPEP1; Prognosis

Indexed keywords

DIPEPTIDASE; DIPEPTIDASE 1; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL STRAIN HT29; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; FAMILIAL COLON POLYPOSIS; FEMALE; GENE EXPRESSION PROFILING; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SERIAL ANALYSIS OF GENE EXPRESSION; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADENOMA; AGED; CACO-2 CELLS; CELL TRANSFORMATION, NEOPLASTIC; COLON; COLORECTAL NEOPLASMS; DIPEPTIDASES; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION; GENES, P53; GPI-LINKED PROTEINS; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; KAPLAN-MEIER ESTIMATE; MALE; MUTATION; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA INTERFERENCE; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 79954429129     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0318-1     Document Type: Article

References (36)

1. L Messerini F Cianchi C Cortesini CE Comin 2006 Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma Hum Pathol 37 1259 1267 10.1016/j.humpath.2006.04.023 16949928 (Pubitemid 44380278)
2. Shih W, Chetty R, Tsao MS. Expression profiling by microarrays in colorectal cancer (review). Oncol Rep. 2005;13:517-24.
3. H Tsukuma W Ajiki A Oshima 2004 Cancer incidence in Japan Gan To Kagaku Ryoho 31 840 846 15222098
4. RS Houlston 2001 What we could do now: molecular pathology of colorectal cancer Mol Pathol 54 206 214 1:CAS:528:DC%2BD38XnvFSjt70%3D 10.1136/mp.54.4.206 11477132 (Pubitemid 32730393)
5. AMM Haydon JR Jass 2002 Emerging pathways in colorectal cancer development Lancet 3 83 88 1:CAS:528:DC%2BD38XitFOjsLc%3D 10.1016/S1470-2045(02) 00649-6 (Pubitemid 34162978)
6. RL Strausberg 2001 The cancer genome anatomy project: new resources for reading the molecular signatures of cancer J Pathol 195 31 40 1:CAS:528:DC%2BD3MXnvVCmtLg%3D 10.1002/1096-9896(200109)195:1<31::AID- PATH920>3.0.CO;2-W 11568889 (Pubitemid 32899043)
7. EM Kozak SS Tate 1982 Glutathione-degrading enzymes of microvillus membranes J Biol Chem 257 6322 6327 1:CAS:528:DyaL38XksFWmu70%3D 6122685 (Pubitemid 12029545)
8. NM Hooper MG Low AJ Turner 1987 Renal dipeptidase is one of the membrane proteins released by phosphatidylinositol-specific phospholipase C Biochem J 244 465 469 1:CAS:528:DyaL2sXktVejur8%3D 2822007 (Pubitemid 17087115)
9. H Adachi Y Tawaragi C Inuzuka I Kubota M Tsujimoto T Nishihara, et al. 1990 Primary structure of human microsomal dipeptidase deduced from molecular cloning J Biol Chem 265 3992 3995 1:CAS:528:DyaK3cXkvFeqs7c%3D 2303490
10. CM McIver JM Lloyd PJ Hewett JE Hardingham 2004 Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma Cancer Lett 209 67 74 1:CAS:528:DC%2BD2cXktVClu74%3D 10.1016/j.canlet.2003.11.033 15145522 (Pubitemid 38625746)
11. S Yajima M Ishii H Matsushita K Aoyagi K Yoshimatsu H Kaneko, et al. 2007 Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer Int J Oncol 31 1029 1037 1:CAS:528:DC%2BD2sXhtlKhsrbJ 17912428
12. VB Aster FA Coller 1954 The prognosis significance of direct extension of carcinoma of the colon and rectum Ann Surg 192 846 850 10.1097/00000658- 195406000-00015
13. E Austruy M Cohen-Salmon C Antignac C Béroud I Henry VC Nguyen, et al. 1993 Isolation of kidney complementary DNAs down-expressed in Wilms' tumor by a subtractive hybridization approach Cancer Res 53 2888 2894 1:CAS:528:DyaK3sXltFSgtLk%3D 7916648 (Pubitemid 23180532)
14. H Nakagawa J Inazawa K Inoue S Misawa K Kashima H Adachi, et al. 1991 Assignment of the human renal dipeptidase gene (DPEP1) to band q24 of chromosome 16 Cytogenet Cell Genet 59 258 260 10.1159/000133263
15. E Austruy C Jeanpierre C Antignac SA Whitmore N Van Cong A Bernheim, et al. 1993 Physical and genetic mapping of the dipeptidase gene DPEP1 to 16q24.3 Genomics 15 684 687 1:CAS:528:DyaK3sXktVahu74%3D 10.1006/geno.1993.1126 7682195 (Pubitemid 23102070)
16. TE Godfrey ML Cher V Chhabra RH Jensen 1997 Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma Cancer Genet Cytogenet 98 36 42 1:CAS:528:DyaK2sXmtl2ltb4%3D 10.1016/S0165-4608(96)00392-5 9309116 (Pubitemid 27400850)
17. K Bando H Nagai S Matsumoto M Koyama N Kawamura T Tajiri, et al. 2000 Identification of a 1-Mb common region at 16q24.1-24.2 deleted in hepatocellular carcinoma Genes Chromosomes Cancer 28 38 44 1:CAS:528:DC%2BD3cXis1Whtb4%3D 10.1002/(SICI)1098-2264(200005)28:1<38::AID-GCC5>3.0.CO;2-A 10738301 (Pubitemid 30176761)
18. M Sato Y Mori A Sakurada S Fukushige Y Ishikawa E Tsuchiya, et al. 1998 Identification of a 910-kb region of common allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer Genes Chromosomes Cancer 22 1 8 1:CAS:528:DyaK1cXjtVeqtr0%3D 10.1002/(SICI)1098-2264(199805)22:1<1::AID- GCC1>3.0.CO;2-1 9591628 (Pubitemid 28217800)
19. M Kawakami J Staub W Cliby L Hartmann DI Smith V Shridhar 1999 Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer Int J Oncol 15 715 720 1:CAS:528:DyaK1MXntVSnsL4%3D 10493953
20. EA Rakha AR Green DG Powe R Roylance IO Ellis 2006 Chromosome 16 tumor-suppressor genes in breast cancer Genes Chromosomes Cancer 45 527 535 1:CAS:528:DC%2BD28XktlCrtbc%3D 10.1002/gcc.20318 16518845 (Pubitemid 43727159)
21. B Vogelstein ER Fearon SE Kern SR Hamilton AC Preisinger Y Nakamura, et al. 1989 Allelotype of colorectal carcinomas Science 244 207 211 1:STN:280:DyaL1M3gtlalsg%3D%3D 10.1126/science.2565047 2565047 (Pubitemid 19110299)
22. TK Weber J Conroy B Keitz M Rodriguez-Bigas NJ Petrelli DL Stoler, et al. 1999 Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer Cytogenet Cell Genet 86 142 147 1:CAS:528:DyaK1MXnsFGhsLo%3D 10.1159/000015368 10545706 (Pubitemid 29488308)
23. Zhou CZ, Qiu GQ, Zhang F, He L, Peng ZH. Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma. World J Gastroenterol. 2004;15(10):1431-5. (Pubitemid 39206805)
24. TJ Slaga 1995 Inhibition of the induction of cancer by antioxidants Adv Exp Med Biol 369 167 174 1:CAS:528:DyaK2MXpslWqsr4%3D 7598004
25. M Nakajima AM Chop 1991 Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors Semin Cancer Biol 2 115 127 1:CAS:528:DyaK3sXlslynsL0%3D 1655116
26. E Karna JA Pałka 2002 Inhibitory effect of acetylsalicylic acid on metalloproteinase activity in human lung adenocarcinoma at different stages of differentiation Eur J Pharmacol 443 1 6 1:CAS:528:DC%2BD38XktFOgsro%3D 10.1016/S0014-2999(02)01557-1 12044784 (Pubitemid 34603590)
27. JS Mandel JH Bond TR Church DC Snover GM Bradley LM Schuman, et al. 1993 Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study N Engl J Med 328 1365 1371 1:STN:280:DyaK3s3jtlOhtQ%3D%3D 10.1056/NEJM199305133281901 8474513 (Pubitemid 23131388)
28. JD Hardcastle JO Chamberlain MH Robinson SM Moss SS Amar TW Balfour, et al. 1996 Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1472 1477 1:STN:280:DyaK2s%2FpvVagtg%3D%3D 10.1016/S0140-6736(96)03386-7 8942775 (Pubitemid 26400242)
29. O Kronborg C Fenger J Olsen OD Jørgensen O Søndergaard 1996 Randomized study of screening for colorectal cancer with faecal-occult-blood test Lancet 348 1467 1471 1:STN:280:DyaK2s%2FpvVagsQ%3D%3D 10.1016/S0140- 6736(96)03430-7 8942774 (Pubitemid 26400241)
30. JS Mandel TR Church JH Bond F Ederer MS Geisser SJ Mongin, et al. 2000 The effect of fecal occult-blood screening on the incidence of colorectal cancer N Engl J Med 343 1603 1607 1:STN:280:DC%2BD3M%2FktFSntg%3D%3D 10.1056/NEJM200011303432203 11096167 (Pubitemid 32162983)
31. SM Dong G Traverso C Johnson L Geng R Favis K Boynton, et al. 2001 Detecting colorectal cancer in stool with the use of multiple genetic targets J Natl Cancer Inst 93 858 865 1:CAS:528:DC%2BD3MXltVOhu7Y%3D 10.1093/jnci/93.11. 858 11390535 (Pubitemid 32586613)
32. G Traverso A Shuber B Levin C Johnson L Olsson DJ Schoetz Jr, et al. 2002 Detection of APC mutations in fecal DNA from patients with colorectal tumors N Engl J Med 346 311 320 1:CAS:528:DC%2BD38XpsVyktA%3D%3D 10.1056/NEJMoa012294 11821507 (Pubitemid 34438838)
33. Y Matsumura D Tarin 1992 Significance of CD44 gene products for cancer diagnosis and disease evaluation Lancet 340 1053 1058 1:CAS:528: DyaK3sXhsVClsLg%3D 10.1016/0140-6736(92)93077-Z 1357452
34. Y Matsumura D Hanbury J Smith D Tarin 1994 Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells BMJ 308 619 624 1:STN:280:DyaK2c7pvVOjsg%3D%3D 8148709
35. NCI. Cancer Genome Anatomy Project: GeneFinder. Bethesda: National Cancer Institute. http://cgap.nci.nih.gov/Genes/GeneFinder. Accessed 15 Dec 2005.
36. M Ohue N Tomita T Monden M Fujita M Fukunaga K Takami, et al. 1994 A frequent alteration of p53 gene in carcinoma in adenoma of colon Cancer Res 54 4798 4804 1:CAS:528:DyaK2cXlvFOnsrs%3D 8062281 (Pubitemid 24276515)